FINWIRES · TerminalLIVE
FINWIRES

Saudi Arabia's Construction Activity Rises in August Amid Higher New Orders

By
Saudi Arabia's Construction Activity Rises in August Amid Higher New Orders

Construction activity in Saudi Arabia improved for the fourth straight month in August amid a sustained increase in new orders, according to alrajhi capital and S&P Global's business survey data released Monday.

The headline seasonally adjusted alrajhi capital Saudi Construction Index edged up to 55.4 in August from 55.2 in July, marking the second-highest level since the survey's launch in January.

"Activity increased across all three major segments, while new orders remained strong, with infrastructure recording its fastest rise in new orders since February," said Sultan Altowaim, alrajhi capital's head of research. "The operating environment remained supportive, with quantity purchased (by construction companies) rising at its fastest pace since the survey began, and suppliers' delivery times improving for a fourth consecutive month."

New work across the construction sector rose sharply in August, with the infrastructure and residential segments seeing an increase in new orders. This was supported regional development, utilities investments, new roads and transport connectivity projects, among other factors, amid improving market conditions.

The non-residential structures segment also saw a "solid" pace of growth in business activity as work on projects restarted on the back of better economic conditions.

Meanwhile, purchasing activity saw its sharpest rise thus far in 2026 as supply conditions also improved for the fourth consecutive month in August despite ongoing disruptions in international shipping. Input buying also increased as input price inflation picked up amid higher costs related to transportation and raw materials.

"Although input cost inflation accelerated during August, firms remained optimistic about the outlook, supported by healthy project pipelines and expectations of continued activity growth," Altowaim added.

Related Articles

Ingenia Communities Rejects Warburg Pincus' AU$1.94 Billion Takeover Bid
US Markets

Ingenia Communities Rejects Warburg Pincus' AU$1.94 Billion Takeover Bid

Ingenia Communities (ASX:INA) has rejected Walberg Pincus' unsolicited offer to take over the property group for AU$1.94 billion, saying the proposal "substantially undervalues" the company, according to a Monday filing with the Australian Securities Exchange.The conditional, non-binding proposal, which would take the property group for AU$4.75 per security, "is not in the best interests of its security holders," Ingenia said.Ingenia said it is optimistic about its strategy, underpinned by support from its land lease and holiday accommodation sectors. The company will have opportunities to grow and give long-term value to shareholders, the developer added.The proposal is subject to due diligence, regulatory approvals, and board recommendation, and is contingent on the company abandoning its proposed acquisition of residential developer Peet (ASX:PPC).In late August, Ingenia offered to purchase Peet for AU$0.68 per share and scrip consideration of 0.3367 Ingenia stapled securities per Peet share, valuing Ingenia's peer at AU$992.5 million.Shares in Ingenia surged 14% during the midday session in Sydney.

ASX:INA
Fosun Pharma Plans HK$1 Billion Share Buyback Funded by Gland Pharma Stake Sale
US Markets

Fosun Pharma Plans HK$1 Billion Share Buyback Funded by Gland Pharma Stake Sale

Shanghai Fosun Pharmaceutical (HKG:2196, SHA:600196) plans to repurchase up to HK$1 billion of its H-shares over a 12-month period.The plan, which the Chinese pharmaceutical firm said was designed to address market concerns and bolster shareholder value, will be funded by a divestment in its Indian unit.Fosun's indirect subsidiary, Fosun Pharma Singapore, sold 9.897 million shares in Gland Pharma (NSE:GLAND, BOM:543245) for about 28 billion Indian rupees. The sale was executed through block trades and open-market transactions at an average price of 2,828.78 rupees each, representing a 2.72% discount to the previous close.The sale reduces Fosun International's equity stake in Gland Pharma to 45.76% from 51.76%. Gland Pharma will remain a subsidiary of Fosun Pharma and its financial results will continue to be consolidated under Fosun's umbrella.The share buyback follows an upbeat first half for Fosun Pharma. Attributable net profit jumped 19.1% year over year to 1.14 billion yuan on the back of a 4.75% increase in revenue to 20.4 billion yuan."Looking ahead, Fosun Pharma will stay focused on innovation and globalization, accelerating the R&D progress and commercialization of its major pipeline candidates," the company said.Fosun Pharma's shares jumped more than 7% in Hong Kong and over 1% in Shanghai in recent trade.

BOM:543245HKG:2196NSE:GLANDSHA:600196
Australian Job Ads Rise in August, But Poised to Trend Lower as Economic Momentum Fades
US Markets

Australian Job Ads Rise in August, But Poised to Trend Lower as Economic Momentum Fades

Labor demand in Australia remained resilient in August with a rise in the number of job advertisements, but the volume of ads is expected to trend lower over the coming months as the impact of the central bank's monetary tightening takes hold.ANZ-Indeed Australian Job Ads, a monthly indicator that tracks the total number of internet job advertisements across select websites, rose by a seasonally adjusted 2.5% month over month in August following an upwardly revised 1.9% increase in July, ANZ Research said in a Monday release.The growth was driven by notable gains across Victoria, Western Australia, and Queensland as local businesses started Christmas-related hiring, leading to a surge in retail and food service roles, the data showed.The education and cleaning and sanitation sectors also posted strong gains, but tech-related hiring continued to slow, with software development, data and analytics, and other tech roles seeing a modest decline in demand in recent months.But as labor market conditions typically respond to changes in economic activity with a lag, ANZ expects job ad volume to gradually decline as economic momentum softens and higher interest rates act as a restraint on demand.The Reserve Bank of Australia raised borrowing costs three times this year, but held the rate at 4.35% at its two most recent meetings in June and August. More hikes may be on the cards as policymakers remain concerned about upside risks to inflation, which remains above target.Australia's seasonally adjusted unemployment rate increased to 4.5% in July from 4.4% in the previous month as employment fell by 15,800 people, official Australian Bureau of Statistics data showed in August."While the ABS highlighted larger-than-usual uncertainty around the estimates, we continue to expect labor market conditions to ease and unemployment to drift higher gradually over the months ahead," said Jasmine Zheng, a senior economist at ANZ. But given the resilience of the ANZ-Indeed series, "we expect the rise in the unemployment rate to be modest," Zheng said.

ASX 200